Teiko Sakai

发表

Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis

K. Hanawa, S. Ishii, H. Sugiyama, 2018, Genetics in Medicine.

Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis

K. Hanawa, S. Ishii, H. Sugiyama, 2018, Genetics in Medicine.

Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis

K. Hanawa, S. Ishii, H. Sugiyama, 2018, Genetics in Medicine.

Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis

K. Hanawa, S. Ishii, H. Sugiyama, 2018, Genetics in Medicine.

Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis

K. Hanawa, S. Ishii, H. Sugiyama, 2019, Genetics in Medicine.